Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event
November 21, 2024 18:33 ET
|
Immuron Limited
MELBOURNE, Australia, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief Executive Officer, Steven Lydeamore presented early this morning at...
Beneficient Reports to Kansas Legislative Committee on Its Positive Developments and the Digital Transformation of the Alternative Asset Industry
November 21, 2024 18:15 ET
|
Beneficient
today provided an update to a Kansas legislators about its business operations and related economic development for the benefit of the state's communities.
Inspirato Partners with BLADE Urban Air Mobility to Enhance Member Travel Experiences
November 21, 2024 17:32 ET
|
Inspirato Incorporated
DENVER, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Inspirato Incorporated (“Inspirato” or the “Company”) (NASDAQ: ISPO), the premier members-only luxury vacation club, announced a strategic partnership with...
NVIDIA Announces Upcoming Events for Financial Community
November 21, 2024 17:00 ET
|
NVIDIA
SANTA CLARA, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- NVIDIA will present at the following events for the financial community: UBS Global Technology and AI ConferenceTuesday, Dec. 3, 6:35 a.m....
Bleichroeder Acquisition Corp. I Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing December 2, 2024
November 21, 2024 16:57 ET
|
Bleichroeder Acquisition Corp. I
New York, NY, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Bleichroeder Acquisition Corp. I (Nasdaq: BACQU) (the “Company”) announced today that, commencing December 2, 2024, holders of the units sold in the...
Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C
November 21, 2024 16:51 ET
|
Zevra Therapeutics
MIPLYFFA, the first FDA-approved treatment for Niemann-Pick disease type C, is available at Zevra’s specialty pharmacy for dispense AmplifyAssist™, Zevra’s comprehensive patient support program, in...
BioXcel Therapeutics Announces Proposed Public Offering
November 21, 2024 16:47 ET
|
BioXcel Therapeutics
NEW HAVEN, Conn., Nov. 21, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop...
CONNEXA HAS CLOSED THE ACQUISITION OF A FURTHER 50% OF YYEM AND CONFIRMS THAT TRADING OF THE POST-ACQUISITION YYAI WILL COMMENCE FRIDAY, NOVEMBER 22, 2024
November 21, 2024 16:47 ET
|
Connexa Sports Technologies Inc.
Windsor Mills, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Connexa Sports Technologies Inc. (Nasdaq:YYAI) is pleased to announce that it has closed the acquisition of a further 50% ownership stake in Yuanyu...
Expand Energy Corporation Announces Pricing of Senior Notes Offering
November 21, 2024 16:37 ET
|
Expand Energy Corporation
OKLAHOMA CITY, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Expand Energy Corporation (NASDAQ: EXE) (“Expand Energy”) announced today the pricing of its offering (the “Notes Offering”) of $750,000,000...
5E Advanced Materials Provides Shareholder Update Call Highlighting By-Product Decision and First Commercial Delivery of Boric Acid
November 21, 2024 16:30 ET
|
5E Advanced Materials, Inc.
HESPERIA, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”), a boron and lithium company with U.S. government Critical...